These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 21211520

  • 21. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 22. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
    Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F.
    Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
    [Abstract] [Full Text] [Related]

  • 23. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus.
    Skrha J, Kalousová M, Svarcová J, Muravská A, Kvasnička J, Landová L, Zima T, Skrha J.
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):277-81. PubMed ID: 22549347
    [Abstract] [Full Text] [Related]

  • 24. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
    Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S.
    Int J Cancer; 2013 Dec 01; 133(11):2619-30. PubMed ID: 23729200
    [Abstract] [Full Text] [Related]

  • 25. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1.
    Pullerits R, Brisslert M, Jonsson IM, Tarkowski A.
    Arthritis Rheum; 2006 Dec 01; 54(12):3898-907. PubMed ID: 17133598
    [Abstract] [Full Text] [Related]

  • 26. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M, Jáchymová M, Mestek O, Hodková M, Kazderová M, Tesar V, Zima T.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):2020-6. PubMed ID: 17347281
    [Abstract] [Full Text] [Related]

  • 27. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
    Yokota C, Minematsu K, Tomii Y, Naganuma M, Ito A, Nagasawa H, Yamaguchi T.
    J Neurol Sci; 2009 Dec 15; 287(1-2):41-4. PubMed ID: 19801152
    [Abstract] [Full Text] [Related]

  • 28. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E.
    Clin Biochem; 2008 Aug 15; 41(12):981-5. PubMed ID: 18538667
    [Abstract] [Full Text] [Related]

  • 29. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z, Germanová A, Koucký M, Zima T, Kopecký P, Vítkova M, Parízek A, Kalousová M.
    J Perinat Med; 2008 Aug 15; 36(5):399-404. PubMed ID: 18771410
    [Abstract] [Full Text] [Related]

  • 30. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H, Gao J, Pulkkinen V, Toljamo T, Nieminen P, Mazur W.
    BMC Pulm Med; 2014 Apr 24; 14():68. PubMed ID: 24758342
    [Abstract] [Full Text] [Related]

  • 31. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, Geroldi D.
    Arterioscler Thromb Vasc Biol; 2005 May 24; 25(5):1032-7. PubMed ID: 15731496
    [Abstract] [Full Text] [Related]

  • 32. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.
    Cancer Invest; 2007 Dec 24; 25(8):720-5. PubMed ID: 18058469
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Soluble receptor for advanced glycation end products in patients with decreased renal function.
    Kalousová M, Hodková M, Kazderová M, Fialová J, Tesar V, Dusilová-Sulková S, Zima T.
    Am J Kidney Dis; 2006 Mar 24; 47(3):406-11. PubMed ID: 16490618
    [Abstract] [Full Text] [Related]

  • 35. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study.
    Zakiyanov O, Kriha V, Vachek J, Zima T, Tesar V, Kalousova M.
    BMC Nephrol; 2013 Nov 04; 14():245. PubMed ID: 24188108
    [Abstract] [Full Text] [Related]

  • 36. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Neurol Scand; 2009 Aug 04; 120(2):119-22. PubMed ID: 19053950
    [Abstract] [Full Text] [Related]

  • 37. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Diabetes Metab Res Rev; 2008 Feb 04; 24(2):109-14. PubMed ID: 17694504
    [Abstract] [Full Text] [Related]

  • 38. Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury.
    Izushi Y, Teshigawara K, Liu K, Wang D, Wake H, Takata K, Yoshino T, Takahashi HK, Mori S, Nishibori M.
    J Pharmacol Sci; 2016 Apr 04; 130(4):226-34. PubMed ID: 27038888
    [Abstract] [Full Text] [Related]

  • 39. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
    Yoon SJ, Park S, Park C, Chang W, Cho DK, Ko YG, Choi D, Kwon HM, Jang Y, Chung N.
    Coron Artery Dis; 2012 Mar 04; 23(2):85-90. PubMed ID: 22198512
    [Abstract] [Full Text] [Related]

  • 40. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL.
    Nutr Metab Cardiovasc Dis; 2009 Feb 04; 19(2):129-34. PubMed ID: 18595673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.